Launch of Lexapro commenced in Japan
* Lexapro(®) - the most prescribed branded antidepressant in the world - now also available to Japanese patients * Clinical phase III studies in Japan have confirmed the positive efficacy and tolerability profile of Lexapro(®) * Lexapro(®) in Japan will contribute to Lundbeck's financial performance from 2012 H. Lundbeck A/S today announced that its partners Mochida Pharmaceutical Co.,Ltd. (Mochida) and Mitsubishi Tanabe Pharma Corporation (MTPC) have launchedLexapro(®) 10mg (escitalopram) in Japan, for which Mochida obtained themarketing approval following the NHI (